These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25660084)

  • 21. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mifepristone for induction of second trimester abortion].
    Heimstad R; Backe B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2412-3. PubMed ID: 14560764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
    Rose SB; Shand C; Simmons A
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual [corrected] misoprostol as first-line care for incomplete abortion in Burkina Faso.
    Blandine T; Ouattara AZ; Coral A; Hassane C; Clotaire H; Dao B; Lankoande J; Diop A; Blum J
    Int J Gynaecol Obstet; 2012 Nov; 119(2):166-9. PubMed ID: 22935621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section.
    Cayrac M; Faillie JL; Flandrin A; Boulot P
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):145-9. PubMed ID: 21511389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks' gestation: a case series and systematic review of the literature.
    Kiley J; Turner A; Nosal C; Beestrum M; Dungan J
    Eur J Contracept Reprod Health Care; 2022 Dec; 27(6):486-493. PubMed ID: 35899830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss.
    Valero I; Garcia-Jimenez R; Weber-Fernandez AM; Diaz-Acedo R; Fobelo-Lozano MJ; Cerrillos L; Ostos R
    Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):341-344. PubMed ID: 35403535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal misoprostol and intravenous oxytocin for success of termination in the second-trimester intrauterine fetal demise: A randomized controlled clinical trial.
    Asadi N; Vafaei H; Hessami K; Darabi MH; Kasraeian M; Faraji A; Alavi A; Abdi N; Gissuei A; Roozmeh S; Bazrafshan K; Gharibpour F
    J Obstet Gynaecol Res; 2022 Apr; 48(4):966-972. PubMed ID: 35261120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
    Ho PC; Ngai SW; Liu KL; Wong GC; Lee SW
    Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.
    Hou S; Zhang L; Chen Q; Fang A; Cheng L
    Int J Gynaecol Obstet; 2010 Nov; 111(2):126-30. PubMed ID: 20705290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of misoprostol in termination of second-trimester pregnancy.
    Lin CJ; Chien SC; Chen CP
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):275-82. PubMed ID: 22030039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion.
    Gaye A; Diop A; Shochet T; Winikoff B
    Int J Gynaecol Obstet; 2014 Sep; 126(3):223-6. PubMed ID: 24893962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abortion procedures in a tertiary care institution in India.
    Choudhary N; Saha SC; Gopalan S
    Int J Gynaecol Obstet; 2005 Oct; 91(1):81-6. PubMed ID: 16098979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of Labor Using Misoprostol With or Without Mifepristone in Intrauterine Death.
    Agrawal A; Basnet P; Thakur A; Rizal P; Rai R
    JNMA J Nepal Med Assoc; 2014; 52(194):785-90. PubMed ID: 26905705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Termination of 10-16 weeks's gestation with mifepristone plus misoprostol: a multicentre randomized clinical trial].
    Cheng L
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):268-71. PubMed ID: 11326930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effectiveness and safety of treatment of incomplete second trimester abortion with misoprostol provided by midwives and physicians: a randomised, controlled, equivalence trial in Uganda.
    Atuhairwe S; Byamugisha J; Kakaire O; Hanson C; Cleeve A; Klingberg-Allvin M; Tumwesigye NM; Gemzell-Danielsson K
    Lancet Glob Health; 2022 Oct; 10(10):e1505-e1513. PubMed ID: 36030801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.